Quote | Indaptus Therapeutics Inc. (NASDAQ:INDP)
Last: | $2.005 |
---|---|
Change Percent: | 1.29% |
Open: | $2 |
Close: | $2.005 |
High: | $2.1618 |
Low: | $1.9801 |
Volume: | 11,564 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
News | Indaptus Therapeutics Inc. (NASDAQ:INDP)
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, was proud to unveil its poster at the 2024 Annual Meeting of the American Association for Cance...
Data demonstrates that Company’s Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor responses New data shows activity in M1 macrophages, natural killer cells, dendritic cells, Th1 CD4, and CD8 T cells NEW YORK, March 25, 2024 (...
Message Board Posts | Indaptus Therapeutics Inc. (NASDAQ:INDP)
Subject | By | Source | When |
---|---|---|---|
$INDP MomentumIts gaining | Surfacetite | investorshub | 05/08/2023 8:37:38 AM |
$INDP got some short data | DeadCellShadix | investorshub | 05/08/2023 1:32:26 AM |
Price gaining | Surfacetite | investorshub | 05/07/2023 3:23:16 PM |
$INDP MomentumIts now last trade up | MonstaGains | investorshub | 05/03/2023 4:25:58 PM |
The gaining up | MonstaGains | investorshub | 05/01/2023 7:51:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Indaptus Therapeutics Inc. Company Name:
INDP Stock Symbol:
NASDAQ Market:
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, was proud to unveil its poster at the 2024 Annual Meeting of the American Association for Cance...
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP), a clinical stage biotechnology company dedicated to pion...
Data demonstrates that Company's Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor response...